| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| KELYNIAM GLOBAL Aktie jetzt für 0€ handeln | |||||
| 11.05. | Kelyniam Global reports Q1 results | 1 | Seeking Alpha | ||
| 11.05. | Kelyniam Global Inc: Kelyniam Global Announces Strong Q1 2026 Financial Results | 124 | PR Newswire | CANTON, Conn., May 11, 2026 /PRNewswire/ -- Kelyniam Global (OTC: KLYG), a leader in custom cranial implants, today reported its financial results for the first... ► Artikel lesen | |
| 16.03. | Kelyniam Global reports FY results | 1 | Seeking Alpha | ||
| 16.03. | Kelyniam Global Inc: Kelyniam Global Reports 2025 Financial Results | 202 | PR Newswire | Strong Second-Half Momentum Drives 85% Net Loss Improvement; FDA Clearance Secured for Innovative Fusion Biomaterial Implant; Board Rejects Undervalued Acquisition... ► Artikel lesen | |
| 13.11.25 | Kelyniam Global Inc.: Kelyniam Global Secures Exclusive U.S. License for Evonik's VESTAKEEP Fusion Biomaterial in Cranial Implants | 435 | GlobeNewswire (Europe) | CANTON, Conn., Nov. 13, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today announced it has secured an exclusive U.S. license from... ► Artikel lesen | |
| 10.11.25 | Kelyniam Global Inc: Kelyniam Global Announces Q3 2025 Financial Results | 146 | PR Newswire | CANTON, Conn., Nov. 10, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leader in custom cranial and craniofacial implants, today reported financial results... ► Artikel lesen | |
| 07.11.25 | Kelyniam Global Inc.: Kelyniam Global Renews Licensing Agreement with Finceramica, Unlocking Access to Valuable Pipeline Products | 160 | GlobeNewswire (Europe) | CANTON, Conn., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and cranio-maxillofacial implants, today announced the renewal of its licensing... ► Artikel lesen | |
| 11.08.25 | Kelyniam Global Inc: Kelyniam Global Announces Q2 2025 Financial Results | 335 | PR Newswire | CANTON, Conn., Aug. 11, 2025 /PRNewswire/ -- Kelyniam Global, Inc. (OTC: KLYG), a leading manufacturer of custom cranial and craniofacial implants, today announced... ► Artikel lesen |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BRIGHTSPRING HEALTH SERVICES | 68,98 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 28,510 | 0,00 % | Truist raises Progyny stock price target to $33 on growth outlook | ||
| SIEMENS HEALTHINEERS | 34,220 | -0,52 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,860 | -0,07 % | AKTIE IM FOKUS: FMC auf Hoch seit Februar - Goldman optimistisch für Quartal | FRANKFURT (dpa-AFX Broker) - Die Aktien von FMC haben am Montag mit 41,58 Euro wieder einen Höchststand seit Februar erreicht. Richard Felton von Goldman Sachs ist optimistisch, dass der Dialysekonzern... ► Artikel lesen | |
| FRESENIUS | 39,820 | -0,72 % | FRESENIUS SE & CO KGAA - Stabilität als Fundament | ||
| TALKSPACE | 5,220 | 0,00 % | NSE - Talkspace, Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| HEARTFLOW | 35,680 | +0,08 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 23,155 | -0,15 % | Alignment Healthcare Strengthens Leadership Team to Support Long-Term Growth and Shareholder Value Creation | ORANGE, Calif., May 12, 2026 (GLOBE NEWSWIRE) -- Alignment Healthcare, Inc. (NASDAQ: ALHC) today announced leadership updates that further strengthen the organization as the company continues to scale... ► Artikel lesen | |
| INVO FERTILITY | 2,440 | -0,41 % | INVO Fertility, Inc.: INVO Fertility Reports First Quarter 2026 Results Reflecting Strong Revenue Growth, Expanded Fertility Clinic Platform, and Improved Capital Structure | 23% revenue growth, elimination of all Series C-2 Preferred Stock and warrant liabilities, and a strengthened balance sheet Growth reflects both organic clinic initiatives and acquisition contribution... ► Artikel lesen | |
| BILLIONTOONE | 117,98 | -0,16 % | BillionToOne, Inc.: BillionToOne Reports Fourth Quarter and Full Year 2025 Results and Raises 2026 Revenue Guidance | MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that... ► Artikel lesen | |
| GENEDX | 69,71 | -0,16 % | Piper Sandler raises GeneDx stock price target on coverage policy | ||
| LIFESTANCE HEALTH GROUP | 10,265 | -0,15 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 27,300 | -2,50 % | AKTIE IM FOKUS: Carl Zeiss Meditec ziehen an - Zeiss AG stockt Beteiligung auf | FRANKFURT (dpa-AFX) - Die Aktie des Medizintechnik-Unternehmens Carl Zeiss Meditec hat am Montag einen kräftigen Erholungsschub erhalten. Dass die Carl Zeiss AG ihre Beteiligung aufstocken will, verhalf... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,560 | 0,00 % | Evercore ISI initiates Procept BioRobotics stock with outperform rating | ||
| PRIVIA HEALTH GROUP | 25,530 | -0,16 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2026 Financial Results | Strong First Quarter Performance and Operating ExecutionReiterated Full-Year 2026 Guidance Reflects Continued Momentum ARLINGTON, Va., May 07, 2026 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq:... ► Artikel lesen |